These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3314403)
21. Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether. Sánchez-Crespo M; Fernández-Gallardo S; Nieto ML; Baranès J; Braquet P Immunopharmacology; 1985 Oct; 10(2):69-75. PubMed ID: 3840779 [TBL] [Abstract][Full Text] [Related]
22. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection. Desquand S; Lefort J; Dumarey C; Vargaftig BB Br J Pharmacol; 1991 Mar; 102(3):687-95. PubMed ID: 1285397 [TBL] [Abstract][Full Text] [Related]
23. Platelet activating factor antagonist enhances lung preservation. Corcoran PC; Wang Y; Katz NM; St Louis JD; Foegh ML; Rajan SS; Analouei AR; Wallace RB J Surg Res; 1992 Jun; 52(6):615-20. PubMed ID: 1528038 [TBL] [Abstract][Full Text] [Related]
24. From ginkgolides to N-substituted piperidino-thieno diazepines, a new series of highly potent dual antagonists. Braquet P; Laurent JP; Rolland A; Martin C; Pommier J; Hosford D; Esanu A Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():929-37. PubMed ID: 1825436 [No Abstract] [Full Text] [Related]
25. [Gingkolides and bilobalide: structure, pharmacology, and synthesis]. Sviridov AF Bioorg Khim; 1991 Oct; 17(10):1301-12. PubMed ID: 1804115 [TBL] [Abstract][Full Text] [Related]
26. Effects of the platelet-activating factor antagonist BN 52021 on the hemodynamics of rats with experimental cirrhosis of the liver. Villamediana LM; Sanz E; Fernandez-Gallardo S; Caramelo C; Sanchez Crespo M; Braquet P; Lopez-Novoa JM Life Sci; 1986 Jul; 39(3):201-5. PubMed ID: 3755490 [TBL] [Abstract][Full Text] [Related]
27. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. Baroggi N; Etienne A; Braquet P Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108 [TBL] [Abstract][Full Text] [Related]
28. Potentiation of immunosuppressive action of cyclosporine A by platelet-activating factor antagonists: an approach of the mechanism of action of these drugs in the prevention of graft rejection. Pignol B; Henane S; Pirotzky E; Mencia-Huerta JM; Braquet P Transplant Proc; 1988 Apr; 20(2 Suppl 2):259-65. PubMed ID: 3259039 [No Abstract] [Full Text] [Related]
30. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes. Földes-Filep E; Braquet P; Filep J Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity. Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954 [TBL] [Abstract][Full Text] [Related]
32. Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist. Bagnis C; Deray G; Dubois M; Pirotzky E; Jacquiaud C; Baghos W; Aupetit B; Braquet P; Jacobs C Nephrol Dial Transplant; 1996 Mar; 11(3):507-13. PubMed ID: 8671822 [TBL] [Abstract][Full Text] [Related]
33. Protective effect of a PAF-acether antagonist, BN 52021, in trichothecene toxicosis. Feuerstein G; Leader P; Siren AL; Braquet P Toxicol Lett; 1987 Oct; 38(3):271-4. PubMed ID: 3660430 [TBL] [Abstract][Full Text] [Related]
34. Platelet activating factor and systemic anaphylaxis in Nippostrongylus brasiliensis-sensitized rats: differential effects of PAF antagonists. Mathison R; Davison JS; Befus AD Br J Pharmacol; 1992 Jun; 106(2):263-6. PubMed ID: 1393261 [TBL] [Abstract][Full Text] [Related]
36. Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. Panetta T; Marcheselli VL; Braquet P; Spinnewyn B; Bazan NG Biochem Biophys Res Commun; 1987 Dec; 149(2):580-7. PubMed ID: 2827647 [TBL] [Abstract][Full Text] [Related]
37. The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products. Bazan HE; Reddy ST; Woodland JM; Bazan NG Biochem Biophys Res Commun; 1987 Dec; 149(3):915-20. PubMed ID: 2827658 [TBL] [Abstract][Full Text] [Related]
38. Possible involvement of platelet activating factor in anaphylaxis of passively sensitised, isolated guinea pig hearts. Tosaki A; Koltai M; Braquet P; Szekeres L Cardiovasc Res; 1989 Aug; 23(8):715-22. PubMed ID: 2557156 [TBL] [Abstract][Full Text] [Related]